Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EIF4EBP1 | Q13541 | 11/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.47 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29214612 | 0.86 | EIF4EBP1 (0.47) | EIF4EBP1CYP2C9PTGER1PTGDR2 | |
| SCHEMBL30891724 | 0.86 | EIF4EBP1 (0.47) | EIF4EBP1CYP2C9PTGER1PTGDR2 | |
| SCHEMBL5096044 | 0.81 | PTGER1 (0.62) | EIF4EBP1CYP2C9PTGER1 | |
| SCHEMBL5096241 | 0.81 | PTGER1 (0.54) | EIF4EBP1CYP2C9PTGER1 | |
| SCHEMBL16574049 | 0.81 | TRPV1 (0.50) | — | |
| SCHEMBL14028965 | 0.79 | PTGER1 (0.60) | EIF4EBP1CYP2C9PTGER1 | |
| SCHEMBL14029163 | 0.79 | PTGER1 (0.60) | EIF4EBP1CYP2C9PTGER1 | |
| SCHEMBL5099258 | 0.79 | PTGER1 (0.77) | CYP2C9PTGER1 | |
| SCHEMBL13871664 | 0.78 | SUCNR1 (0.53) | — | |
| SCHEMBL14028869 | 0.78 | PTGER1 (0.59) | EIF4EBP1CYP2C9PTGER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4615848-A1 | COMPOUNDS AND COMPOSITIONS AS EIF4E INHIBITORS AND USES THEREOF | Ribometrix, Inc. (US) | 2025-09-17 | — | — | EP | disclosed |
| US-20240246918-A1 | COMPOUNDS AND COMPOSITIONS AS EIF4E INHIBITORS AND THE USES THEREOF | RIBOMETRIX, INC. | 2024-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240246918-A1 | COMPOUNDS AND COMPOSITIONS AS EIF4E INHIBITORS AND THE USES THEREOF | EIF4E, EIF4EBP1, EIF4A1 | EIF4EBP1 2/4885CYP2C9 4047/4885PTGER1 3948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.